A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

• Status: Withdrawn
• Trial end date: 2018-08-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sutter Gould Medical Foundation

Criteria

Inclusion Criteria:

1. Patients over the age of 18 years old.

2. Being treated by a Sutter Health Physician.

3. Hemoglobin of < 10mg/dl for Men and Women

4. Ferritin

5. Patients in whom oral administration is unsatisfactory or impossible.

Exclusion Criteria:

1. Patients with a history of receiving iron or other hematinic in the preceding 3 months, oral iron is allowable.

2. Anemia due to acute blood loss; menorrhagia is allowed.

3. Patients with a current illness known to interact with iron status.

4. Patients unwilling to consent to required blood draws.

5. Patients who are viewed as unable to complete treatment, based on PI recommendation.